研究目的
Comparing the immediate post-irradiation dermoscopic vascular changes with purpura as a therapeutic endpoint regarding safety and efficacy in PDL treatment of PWS.
研究成果
The immediate post-irradiation vessel disappearance (detected by dermoscope) was comparable in efficacy/safety to purpura and may be more convenient due to being time-saving, more accepted cosmetically, and potentially safer with fewer side effects.
研究不足
The study did not include hypertrophic and/or nodular lesions, pregnant or breast-feeding women, or patients with a history of photosensitive dermatosis. The sample size was limited to 56 patients who completed the study.
1:Experimental Design and Method Selection:
A prospective, single-center randomized trial comparing two therapeutic endpoints in PDL treatment of PWS.
2:Sample Selection and Data Sources:
Sixty patients with PWS nevus were enrolled, with 56 completing the study. Patients were randomized into two groups for treatment.
3:List of Experimental Equipment and Materials:
PDL with a wavelength of 595 nm and a spot size of 10 mm (Dermobeam 2000, DEKA, Italy), Dermlite DL3 dermoscope, Samsung Galaxy mobile phone for image capture,
4:5% lidocaine and 5% prilocaine (EMLA cream) for topical anesthesia. Experimental Procedures and Operational Workflow:
Patients received five monthly PDL sessions with either the lowest dose resulting in 24-hr-lasting purpura or immediate vessel disappearance observed by dermoscope.
5:Data Analysis Methods:
Digital photographs were evaluated by three independent dermatologists to assess the percentage of improvement. Statistical analysis was performed using IBM SPSS Statistics software.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容